PT-141 (bremelanotide) is a synthetic cyclic heptapeptide derived from the Melanotan 2 scaffold, modified by replacing the C-terminal amide with a carboxylic acid. It is investigated in neuroendocrine research for its interactions with central MC3R / MC4R signalling pathways.
- Synthetic cyclic MC3R/MC4R agonist
- Studied in central melanocortin pathway research
- HPLC-verified, lyophilised powder
Supplied strictly for laboratory research purposes only. Not for human consumption, medical use, or veterinary application. Not approved by the MHRA. By purchasing, you confirm use in a qualified research environment.
Reviews
There are no reviews yet.